‘I’ve spent £20,000 on prostate cancer drug – but this new test could save NHS money’

Giles Turner, 64, diagnosed with high-risk prostate cancer in March 2023, has spent £20,000 on the life-extending drug abiraterone, which is free in Wales and Scotland but not universally in England. A new AI test analyzes tumor samples to identify which patients would benefit from abiraterone, potentially saving the NHS money as it reveals that only 25% of men may need the drug. Advocates, including Professor Nick James, urge the UK government to make the drug accessible for free in England, emphasizing the importance of early detection and the financial burden on patients like Giles.

Full Article